Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Management of end-stage renal disease patients with antiphospholipid antibody syndrome
S. Vaidya
Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of end-stage renal disease patients with antiphospholipid antibody syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
antibodies
100%
patients
100%
kidneys
100%
diseases
100%
management
100%
therapy
42%
thrombosis
21%
losses
14%
risks
14%
transplants
14%
heparin
14%
side effects
7%
dialysis
7%
Medicine and Dentistry
Patient
100%
Syndrome
100%
End Stage Renal Disease
100%
Antiphospholipid Antibody
100%
Warfarin
35%
Therapeutic Procedure
21%
Thrombosis
21%
Allograft
21%
Anticoagulant Therapy
21%
Bleeding
14%
Heparin
14%
Development
7%
Side Effect
7%
Complication
7%
Transplantation
7%
Clinical Management
7%
Kidney Graft
7%
Kidney Transplantation
7%
Nursing and Health Professions
Phospholipid Antibody
100%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
83%
Keyphrases
Allograft Loss
33%